Research Article

Risk Factors for Wound Healing After Surgical Removal of Maxillary Odontogenic Cysts

Volume: 7 Number: 3 December 10, 2024
  • Utku Mete
  • Fatih Duman
  • Özlem Saraydaroglu
  • Uygar Levent Demir

Risk Factors for Wound Healing After Surgical Removal of Maxillary Odontogenic Cysts

Abstract

Objective: Odontogenic cyst surgeries are commonly performed procedures, but they may present challenges with wound healing during the postoperative period. However, insufficient research exists on this topic. This study aimed to determine the risk factors linked to incomplete wound healing after removing a benign odontogenic cyst in the maxilla. Methods: This study involved patients who underwent transoral Caldwell–Luc surgery and endoscopic endonasal surgery to treat benign odontogenic cysts located in the maxilla between 2014 and 2024 at the University Hospital. Investigated risk factors included demographic factors (gender, age), medical history (comorbidities, smoking habits), cyst size, and serum inflammatory markers like neutrophil-to-lymphocyte ratio (NLR), platelet-to-lymphocyte ratio, and systemic immune-inflammation index (SII). After 3 months of the postoperative period, patients were classified as either having incomplete or optimal healing. Results: Smoking affected incomplete wound healing (χ² = 6.09, P = .0136). Large cysts are associated with the devel- opment of poor healing (odds ratio (OR) = 7.5, 95% confidence interval (CI) 1.20 to 47.05, P = .0473). Also, high NLR and SII levels were found to be essential factors in suboptimal wound healing (OR = 4.667, 95% CI 0.42 to 52.12, P = .294; OR = 9.1, 95% CI 1.39 to 59.62, P = .037, respectively). Conclusion: This study emphasized the significance of assessing cyst size, smoking status, and inflammatory met- rics like serum NLR and SII before benign odontogenic cyst surgeries. Neutrophil-to-lymphocyte ratio and SII, easily obtained from routine serum tests, may serve as cost-effective prognostic values for wound healing, replacing expen- sive immunological biomarkers.

Keywords

References

  1. Avelar RL, Antunes AA, Carvalho RWF, Bezerra PGCF, Oliveira Neto PJ, Andrade ESS. Odontogenic cysts: a clinicopathological study of 507 cases. J Oral Sci. 2009;51(4):581-586.
  2. Neville BW, Damn DD, Allen CM, Bouquot JE. Oral and Maxillofacial Pathology. 3rd ed. Published online; 2002.
  3. Wright JM, Vered M. Update from the 4th Edition of the World Health Organization Classification of Head and Neck Tumours: odontogenic and Maxillofacial Bone Tumors. Head Neck Pathol. 2017;11(1):68-77.
  4. Soluk-Tekkesin M, Wright JM. The World Health Organization Classification of Odontogenic Lesions: a summary of the changes of the 2022 (5th) Edition. Turk Patoloji Derg. 2022;38(2):168-184.
  5. Safadi A, Kleinman S, Gigi D, et al. Surgical management of odontogenic cysts involving the maxillary sinus: a retrospective study. J Craniomaxillofac Surg. 2020;48(8):800-807.
  6. Hunter P. The inflammation theory of disease. The growing realization that chronic inflammation is crucial in many diseases opens new avenues for treatment. EMBO Rep. 2012;13(11):968-970.
  7. Wang RH, Wen WX, Jiang ZP, et al. The clinical value of neutrophil-to-lymphocyte ratio (NLR), systemic immune-inflammation index (SII), platelet-to-lymphocyte ratio (PLR) and systemic inflammation response index (SIRI) for predicting the occurrence and severity of pneumonia in patients with intracerebral hemorrhage. Front Immunol. 2023;14:1115031.
  8. Howard R, Kanetsky PA, Egan KM. Exploring the prognostic value of the neutrophil-to-lymphocyte ratio in cancer. Sci Rep. 2019;91:1-10.

Details

Primary Language

English

Subjects

Otorhinolaryngology

Journal Section

Research Article

Authors

Özlem Saraydaroglu This is me
0000-0002-4127-9656
Türkiye

Uygar Levent Demir This is me
0000-0002-9590-1420
Türkiye

Publication Date

December 10, 2024

Submission Date

August 12, 2024

Acceptance Date

October 13, 2024

Published in Issue

Year 2024 Volume: 7 Number: 3

APA
Mete, U., Duman, F., Saraydaroglu, Ö., & Demir, U. L. (2024). Risk Factors for Wound Healing After Surgical Removal of Maxillary Odontogenic Cysts. European Journal of Rhinology and Allergy, 7(3), 95-101. https://doi.org/10.5152/ejra.2024.24149
AMA
1.Mete U, Duman F, Saraydaroglu Ö, Demir UL. Risk Factors for Wound Healing After Surgical Removal of Maxillary Odontogenic Cysts. Eur J Rhinol Allergy. 2024;7(3):95-101. doi:10.5152/ejra.2024.24149
Chicago
Mete, Utku, Fatih Duman, Özlem Saraydaroglu, and Uygar Levent Demir. 2024. “Risk Factors for Wound Healing After Surgical Removal of Maxillary Odontogenic Cysts”. European Journal of Rhinology and Allergy 7 (3): 95-101. https://doi.org/10.5152/ejra.2024.24149.
EndNote
Mete U, Duman F, Saraydaroglu Ö, Demir UL (December 1, 2024) Risk Factors for Wound Healing After Surgical Removal of Maxillary Odontogenic Cysts. European Journal of Rhinology and Allergy 7 3 95–101.
IEEE
[1]U. Mete, F. Duman, Ö. Saraydaroglu, and U. L. Demir, “Risk Factors for Wound Healing After Surgical Removal of Maxillary Odontogenic Cysts”, Eur J Rhinol Allergy, vol. 7, no. 3, pp. 95–101, Dec. 2024, doi: 10.5152/ejra.2024.24149.
ISNAD
Mete, Utku - Duman, Fatih - Saraydaroglu, Özlem - Demir, Uygar Levent. “Risk Factors for Wound Healing After Surgical Removal of Maxillary Odontogenic Cysts”. European Journal of Rhinology and Allergy 7/3 (December 1, 2024): 95-101. https://doi.org/10.5152/ejra.2024.24149.
JAMA
1.Mete U, Duman F, Saraydaroglu Ö, Demir UL. Risk Factors for Wound Healing After Surgical Removal of Maxillary Odontogenic Cysts. Eur J Rhinol Allergy. 2024;7:95–101.
MLA
Mete, Utku, et al. “Risk Factors for Wound Healing After Surgical Removal of Maxillary Odontogenic Cysts”. European Journal of Rhinology and Allergy, vol. 7, no. 3, Dec. 2024, pp. 95-101, doi:10.5152/ejra.2024.24149.
Vancouver
1.Utku Mete, Fatih Duman, Özlem Saraydaroglu, Uygar Levent Demir. Risk Factors for Wound Healing After Surgical Removal of Maxillary Odontogenic Cysts. Eur J Rhinol Allergy. 2024 Dec. 1;7(3):95-101. doi:10.5152/ejra.2024.24149

You can find the current version of the Instructions to Authors at: https://www.eurjrhinol.org/en/instructions-to-authors-104

Starting on 2020, all content published in the journal is licensed under the Creative Commons Attribution-NonCommercial (CC BY-NC) 4.0 International
License which allows third parties to use the content for non-commercial purposes as long as they give credit to the original work. This license
allows for the content to be shared and adapted for non-commercial purposes, promoting the dissemination and use of the research published in
the journal.
The content published before 2020 was licensed under a traditional copyright, but the archive is still available for free access.